Laboratorios Ern S.A.
- Address
- Calle De Peru 228
Sponsor Overview
Specializations
Analgesics and Bioequivalence
Research activity includes comparative evaluation of paracetamol formulations in healthy volunteers under fasting conditions, with interest in orally administered pain and fever treatment options and their pharmaceutical equivalence.
- Paracetamol oral formulations
- Orodispersible tablets
- Oral solution comparisons
The focus is on systemic analgesic delivery and the clinical performance of different oral dosage forms.
Urinary Tract Infections
Clinical interest extends to uncomplicated urinary tract infection in adult women, with evaluation of oral fosfomycin options for clinical and microbiological resolution.
- Uncomplicated urinary tract infection (uUTI)
- Adult women with uUTI
- Urinary antibacterial therapy
This area reflects involvement in community-acquired bacterial infections affecting the urinary tract.
Antibacterial Therapy
The sponsor's therapeutic interests include fosfomycin-based treatment approaches, with attention to agents used in bacterial infection management and oral antibiotic administration.
- Fosfomycin calcium
- Fosfomycin trometamol
- Oral antibacterial treatment
Research activity is centered on antimicrobial options relevant to urinary pathogens.
Sponsored Trials
Data & Insights
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 2 sites across their trial portfolio.
Therapeutic Focus
- 1.Bacterial Infections and Mycoses1 trial180 other sponsors
- 2.Not possible to specify1 trial220 other sponsors
Partnered Research Centres
2 centres- Address
- Carrer De San Quinti 89, 08041 Barcelona
- Address
- Jose Achotegui Kalea S/N, 01009 Vitoria-Gasteiz
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Laboratorios Ern S.A..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

